AMGN vs ZBH
By Alex · Tickerpine
Amgen Inc. vs Zimmer Biomet Holdings, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | ZBH |
|---|---|---|
| Price | $358.33 | $93.10 |
| Market cap | $193.39B | $18.01B |
| P/E ratio | 24.9 | 24.1 |
| ROE | 101.32% | 6.07% |
| Profit margin | 20.96% | 9.05% |
| Revenue growth | 5.80% | 9.30% |
| Dividend yield | 2.81% | 1.03% |
| Beta | 0.42 | 0.47 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs ZBH in plain English
- AMGN is the bigger company — about 10.7× the market cap of ZBH.
- ZBH is cheaper on earnings (P/E 24.1 vs 24.9).
- AMGN earns a higher return on equity (101% vs 6%).
- ZBH is growing revenue faster (9% vs 6%).
- AMGN has the higher dividend yield (2.81% vs 1.03%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
ZBH return calculator
See what $1,000 in Zimmer Biomet Holdings, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.